Skip to main content

Fredun Pharmaceuticals Share Price

1434.60

-37.20(2.53%)

Live Fredun Pharmaceuticals Share Price Chart

Fredun Pharmaceuticals Performance

Days Range

Previous Close₹1,471.80
Open₹1,469
Volume10,306
Day's Range₹1,415.00 - ₹1,469.00
52W Range₹1,400.00 - ₹1,590.00
Market Cap₹2,373.46 Cr

Fredun Pharmaceuticals Fundamentals

ROCE(TTM)17.24
P/E Ratio (TTM)54.16
P/B Ratio8.82
Industry P/E37.20
Debt to Equity0.8
ROE11.73
EPS (TTM)26.5
Dividend Yield0.02
Book Value162.78
Face Value10
ROCE(TTM)17.24
P/E Ratio (TTM)54.16
P/B Ratio8.82
Industry P/E37.20
Debt to Equity0.8
ROE11.73
EPS (TTM)26.5
Dividend Yield0.02
Book Value162.78
Face Value10

Fredun Pharmaceuticals Financials

Sep 2025Dec 2025Mar 2026Jun 2026
Net Sales143.59159.93210.41227.76
Expenses124.85136.37187.32199.08
Profit before tax12.7114.0011.2520.55
Operating Profit9.4310.4810.7813.13
Net Profit9.4310.4810.7813.13
EPS in Rs19.9822.1919.7023.82

Fredun Pharmaceuticals Shareholding Pattern

Promoters
44.57%
Retail And Others
51.43%
Foreign Institutional Investors
1.06%
Domestic Institutional Investors
2.94%

About Fredun Pharmaceuticals

Incorported in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietory firm, for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind. In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.

Parent Organisation
Indian Private
Managing Director
Fredun N Medhora
Founded
1987
NSE Symbol
FREDUN

Fredun Pharmaceuticals Share Price History

Data is not available currently. Please check back later.

Top Mutual Funds Invested in Fredun Pharmaceuticals Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,902.4Price decrease
-1.60 (-0.08%)
₹4,56,089.581,548.0 - 2,046.9
Divis Laboratories Ltd8,597.0Price increase
27.00 (0.32%)
₹2,26,975.645,636.5 - 8,674.0
Torrent Pharmaceuticals Ltd4,896.5Price decrease
-108.50 (-2.17%)
₹1,85,638.533,480.6 - 5,250.0
Cipla Ltd1,432.2Price decrease
-5.80 (-0.40%)
₹1,15,216.021,165.7 - 1,673.0
Zydus Lifesciences Ltd1,120.0Price increase
12.30 (1.11%)
₹1,11,720.43835.5 - 1,205.0
Lupin Ltd2,201.8Price increase
0.30 (0.01%)
₹1,00,271.101,875.0 - 2,529.5

Fredun Pharmaceuticals Ltd FAQs

Yes, You can buy Fredun Pharmaceuticals Ltd (FREDUN) shares by opening a Demat account with Angel One.
Fredun Pharmaceuticals Ltd (FREDUN) share can be bought through the following modes:
1. Direct investment: You can buy Fredun Pharmaceuticals Ltd (FREDUN) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Fredun Pharmaceuticals Ltd (FREDUN) shares.

Open Free Demat Account!

Join our 3.8 Cr+ happy customers

+91
Top Losers

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91